The Function of Memory CD8+ T Cells in Immunotherapy for Human Diseases

키워드

참고문헌 (99)

1. Ahmed R, "Immunological memory and protective immunity : understanding their relation", Science, 272, pp.54~60 (1996)
2. Veiga-Fernandes H, "Response of naïve and memory CD8+ T cells to antigen stimulation in vivo", Nat Immunol, 1, pp.47~53 (2000)
3. Martin MD, "Defining memory CD8 T cell", Front Immunol, 9, pp.2692~ (2018)
4. Surh CD, "Homeostasis of naive and memory T cells", Immunity, 29, pp.848~862 (2008)
5. Harty JT, "Shaping and reshaping CD8+ T-cell memory", Nat Rev Immunol, 8, pp.107~119 (2008)
6. Li Y, "Immunotherapeutic potential of T memory stem cells", Front Oncol, 11, pp.723888~ (2021)
7. Baharom F, "Systemic vaccination induces CD8+ T cells and remodels the tumor microenvironment", Cell, 185, pp.4317~4332 (2022)
8. Mateus J, "Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans", Science, 370, pp.89~94 (2020)
9. Moss P, "The T cell immune response against SARS-CoV-2", Nat Immunol, 23, pp.186~193 (2022)
10. Principe N, "Tumor infiltrating effector memory antigen-specific CD8+ T cells predict response to immune checkpoint therapy", Front Immunol, 11, pp.584423~ (2020)
11. Blanc C, "Targeting resident memory T cells for cancer immunotherapy", Front Immunol, 9, pp.1722~ (2018)
12. Mami-Chouaib F, "Resident memory T cells, critical components in tumor immunology", J Immunother Cancer, 6, pp.87~ (2018)
13. Blum JS, "Pathways of antigen processing", Annu Rev Immunol, 31, pp.443~473 (2013)
14. Reiser J, "Effector, memory, and dysfunctional CD8+ T cell fates in the antitumor immune response", J Immunol Res, 2016, pp.8941260~ (2016)
15. Kaech SM, "Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection", Immunity, 27, pp.393~405 (2007)
16. Xu Y, "Closely related T-memory stem cells correlate with in vivo expansion of CAR. CD19-T cells and are preserved by IL-7 and IL-15", Blood, 123, pp.3750~3759 (2014)
17. Sallusto F, "Two subsets of memory T lymphocytes with distinct homing potentials and effector functions", Nature, 401, pp.708~712 (1999)
18. Joshi NS, "Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor", Immunity, 27, pp.281~295 (2007)
19. Kallies A, "Blimp-1 transcription factor is required for the differentiation of effector CD8+ T cells and memory responses", Immunity, 31, pp.283~295 (2009)
20. Wherry EJ, "Lineage relationship and protective immunity of memory CD8 T cell subsets", Nat Immunol, 4, pp.225~234 (2003)
21. Schenkel JM, "Tissue-resident memory T cells", Immunity, 41, pp.886~897 (2014)
22. Mackay LK, "Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes", Science, 352, pp.459~463 (2016)
23. Gattinoni L, "T memory stem cells in health and disease", Nat Med, 23, pp.18~27 (2017)
24. Lugli E, "Stem, effector, and hybrid states of memory CD8+ T cells", Trends Immunol, 41, pp.17~28 (2020)
25. Hamann D, "Phenotypic and functional separation of memory and effector human CD8+ T cells", J Exp Med, 186, pp.1407~1418 (1997)
26. Verma K, "Human CD8+ CD57-TEMRA cells : too young to be called"old"", PLoS One, 12, pp.e0177405~ (2017)
27. Hamann D, "Evidence that human CD8+CD45RA+CD27-cells are induced by antigen and evolve through extensive rounds of division", Int Immunol, 11, pp.1027~1033 (1999)
28. Gerlach C, "The chemokine receptor CX3CR1 defines three antigen-experienced CD8 T cell subsets with distinct roles in immune surveillance and homeostasis", Immunity, 45, pp.1270~1284 (2016)
29. Swanson PA 2nd, "Discovery and characterization of a novel antiviral CD8 T cell response", pp.2009
30. Nolz JC, "Division-linked generation of death-intermediates regulates the numerical stability of memory CD8 T cells", Proc Natl Acad Sci U S A, 109, pp.6199~6204 (2012)
31. Schluns KS, "Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo", Nat Immunol, 1, pp.426~432 (2000)
32. Tan JT, "Interleukin(IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells", J Exp Med, 195, pp.1523~1532 (2002)
33. Judge AD, "Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8+ T cells", J Exp Med, 196, pp.935~946 (2002)
34. 홍지화, "Effect of Human or Mouse IL-7 on the Homeostasis of Porcine T Lymphocytes", Immune Network, 21(3), pp.1~13 (2021), 대한면역학회[DOI]
35. 최한별, "The Roles of CCR7 for the Homing of Memory CD8+ T Cells into Their Survival Niches", Immune Network, 20(3), pp.1~15 (2020), 대한면역학회[DOI]
36. Carrette F, "IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis", Semin Immunol, 24, pp.209~217 (2012)
37. Vahidi Y, "Memory CD4+ T cell subsets in tumor draining lymph nodes of breast cancer patients : a focus on T stem cell memory cells", Cell Oncol(Dordr), 41, pp.1~11 (2018)
38. Stonier SW, "Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation", Blood, 112, pp.4546~4554 (2008)
39. Dzhagalov I, "The anti-apoptotic Bcl-2 family member Mcl-1 promotes T lymphocyte survival at multiple stages", J Immunol, 181, pp.521~528 (2008)
40. Tarasenko TN, "Cytochrome C oxidase activity is a metabolic checkpoint that regulates cell fate decisions during T cell activation and differentiation", Cell Metab, 25, pp.1254~1268 (2017)
41. Tian Y, "IL-21 and T cell differentiation : consider the context", Trends Immunol, 37, pp.557~568 (2016)
42. Moroz A, "IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity : comparative evaluation of IL-2, IL-15, and IL-21", J Immunol, 173, pp.900~909 (2004)
43. Geltink RI, "Unraveling the complex interplay between T cell metabolism and function", Annu Rev Immunol, 36, pp.461~488 (2018)
44. Lochner M, "Fatty acid metabolism in the regulation of T cell function", Trends Immunol, 36, pp.81~91 (2015)
45. Pearce EL, "Enhancing CD8 T-cell memory by modulating fatty acid metabolism", Nature, 460, pp.103~107 (2009)
46. Ecker C, "Differential reliance on lipid metabolism as a salvage pathway underlies functional differences of T cell subsets in poor nutrient environments", Cell Reports, 23, pp.741~755 (2018)
47. Pan Y, "Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism", Nature, 543, pp.252~256 (2017)
48. Cui G, "Il-7-induced glycerol transport and tag synthesis promotes memory CD8+ T cell longevity", Cell, 161, pp.750~761 (2015)
49. van der Windt GJ, "Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development", Immunity, 36, pp.68~78 (2012)
50. Li J, "Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress", Oncogene, 36, pp.4901~4912 (2017)
51. Overacre-Delgoffe AE, "Regulation of tissue-resident memory T cells by the Microbiota", Mucosal Immunol, 15, pp.408~417 (2022)
52. Bachem A, "Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8+ T cells", Immunity, 51, pp.285~297 (2019)
53. Laidlaw BJ, "Production of IL-10 by CD4+ regulatory T cells during the resolution of infection promotes the maturation of memory CD8+ T cells", Nat Immunol, 16, pp.871~879 (2015)
54. Gallo A, "How can biology of aging explain the severity of COVID-19 in older adults", Clin Geriatr Med, 38, pp.461~472 (2022)
55. Geiger H, "Aging in the lympho-hematopoietic stem cell compartment", Trends Immunol, 30, pp.360~365 (2009)
56. Weng NP, "CD28-T cells : their role in the age-associated decline of immune function", Trends Immunol, 30, pp.306~312 (2009)
57. Chiu WK, "Generation and growth of CD28nullCD8+ memory T cells mediated by IL-15 and its induced cytokines", J Immunol, 177, pp.7802~7810 (2006)
58. Saurwein-Teissl M, "Lack of antibody production following immunization in old age : association with CD8+CD28-T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines", J Immunol, 168, pp.5893~5899 (2002)
59. Sasaki S, "Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies", J Clin Invest, 121, pp.3109~3119 (2011)
60. Craig DJ, "Resident memory T cells and their effect on cancer", Vaccines(Basel), 8, pp.562~ (2020)
61. Manjarrez-Orduño N, "Circulating T cell subpopulations correlate with immune responses at the tumor site and clinical response to PD1 inhibition in non-small cell lung cancer", Front Immunol, 9, pp.1613~ (2018)
62. Bello E, "Elevated circulating memory T cells precede immunotherapy toxicities in melanoma", Trends Cancer, 8, pp.347~349 (2022)
63. Wherry EJ, "T cell exhaustion", Nat Immunol, 12, pp.492~499 (2011)
64. Blank CU, "Defining ‘T cell exhaustion’", Nat Rev Immunol, 19, pp.665~674 (2019)
65. West EE, "Tight regulation of memory CD8+ T cells limits their effectiveness during sustained high viral load", Immunity, 35, pp.285~298 (2011)
66. Kumar R, "Increased sensitivity of antigen-experienced T cells through the enrichment of oligomeric T cell receptor complexes", Immunity, 35, pp.375~387 (2011)
67. Shakiba M, "TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion", J Exp Med, 219, pp.e20201966~ (2022)
68. Jarnicki AG, "Suppression of antitumor immunity by IL-10 and TGF-β-producing T cells infiltrating the growing tumor : influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells", J Immunol, 177, pp.896~904 (2006)
69. Sawant DV, "Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion", Nat Immunol, 20, pp.724~735 (2019)
70. Corbett KS, "SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness", Nature, 586, pp.567~571 (2020)
71. Verbeke R, "Three decades of messenger RNA vaccine development", Nano Today, 28, pp.100766~ (2019)
72. Garcia-Beltran WF, "COVID-19-neutralizing antibodies predict disease severity and survival", Cell, 184, pp.476~488 (2021)
73. Cao Y, "Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies", Nature, 602, pp.657~663 (2022)
74. Liu J, "Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron", Nature, 603, pp.493~496 (2022)
75. Jung MK, "BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality", Nat Microbiol, 7, pp.909~917 (2022)
76. Melchionda F, "Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool", J Clin Invest, 115, pp.1177~1187 (2005)
77. Bai C, "Fusion cytokines IL-7-linker-IL-15 promote mycobacterium tuberculosis subunit vaccine to induce central memory like T cell-mediated immunity", Vaccines(Basel), 8, pp.715~ (2020)
78. Rosenberg SA, "Adoptive cell transfer : a clinical path to effective cancer immunotherapy", Nat Rev Cancer, 8, pp.299~308 (2008)
79. Yang F, "Adoptive cellular therapy(ACT)for cancer treatment", Adv Exp Med Biol, 909, pp.169~239 (2016)
80. Arstila TP, "A direct estimate of the human αβ T cell receptor diversity", Science, 286, pp.958~961 (1999)
81. Nikolich-Žugich J, "The many important facets of T-cell repertoire diversity", Nat Rev Immunol, 4, pp.123~132 (2004)
82. de Greef PC, "The naive T-cell receptor repertoire has an extremely broad distribution of clone sizes", eLife, 9, pp.e49900~ (2020)
83. Yee C, "Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma : in vivo persistence, migration, and antitumor effect of transferred T cells", Proc Natl Acad Sci U S A, 99, pp.16168~16173 (2002)
84. Klebanoff CA, "Central memory self", tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells, 2005, pp.102, 9571~9576
85. Beumer-Chuwonpad A, "The potential of tissue-resident memory t cells for adoptive immunotherapy against cancer", Cells, 10, pp.2234~ (2021)
86. Dudley ME, "Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes", Science, 298, pp.850~854 (2002)
87. Hupperetz Cedric, "CAR T Cell Immunotherapy Beyond Haematological Malignancy", Immune Network, 22(1), pp.1~19 (2022), 대한면역학회[DOI]
88. Curran KJ, "Chimeric antigen receptors for T cell immunotherapy : current understanding and future directions", J Gene Med, 14, pp.405~415 (2012)
89. June CH, "CAR T cell immunotherapy for human cancer", Science, 359, pp.1361~1365 (2018)
90. Baumeister SH, "Phase I trial of autologous CAR T cells targeting NKG2D ligands in patients with AML", MDS and multiple myeloma, 2019, pp.7, 100~112
91. Gumber D, "Improving CAR-T immunotherapy : overcoming the challenges of T cell exhaustion", EBioMedicine, 77, pp.103941~ (2022)
92. Sterner RC, "CAR-T cell therapy : current limitations and potential strategies", Blood Cancer J, 11, pp.69~ (2021)
93. Golubovskaya V, "Different subsets of T cells, memory, effector functions, and CAR-T immunotherapy", Cancers(Basel), 8, pp.36~ (2016)
94. Gargett T, "Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2", Cytotherapy, 17, pp.487~495 (2015)
95. Zhou J, "Chimeric antigen receptor T(CAR-T)cells expanded with IL-7", IL-15 mediate superior antitumor effects, 2019, pp.10, 764~769
96. He C, "Co-expression of IL-7 improves NKG2D-based CAR T cell therapy on prostate cancer by enhancing the expansion and inhibiting the apoptosis and exhaustion", Cancers(Basel), 12, pp.1969~ (2020)
97. Shum T, "Constitutive signaling from an engineered IL7 receptor promotes durable tumor elimination by tumor-redirected T cells", Cancer Discov, 7, pp.1238~1247 (2017)
98. Rostamian H, "A metabolic switch to memory CAR T cells : Implications for cancer treatment", Cancer Lett, 500, pp.107~118 (2021)
99. Shen L, "Metabolic reprogramming by ex vivo glutamine inhibition endows CAR-T cells with less-differentiated phenotype and persistent antitumor activity", Cancer Lett, 538, pp.215710~ (2022)

관련 논문AI추천